How long after neutrophil recovery should myeloid growth factors be continued in autologous hematopoietic stem cell transplant recipients?

Bone Marrow Transplantation

Volumn 33, Issue 7, 2004, Pages 715-719

  Verma, A ^a   Pedicano, J ^a   Trifilio, S ^a   Singhal, S ^a   Tallman, M ^a   Winter, J ^a   Williams, S ^a   Gordon, L ^a   Monreal, J ^a   Mehta, J ^a,b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NONE   (United States)

Author keywords

Autologous hematopoietic stem cell transplantation; Engraftment; Filgrastim; Neutropenia; Sargramostim

Indexed keywords

BUSULFAN; CARBOPLATIN; CARMUSTINE; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; CYTARABINE; ETOPOSIDE; GROWTH FACTOR; MELPHALAN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; THIOTEPA;

ADULT; AGED; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; AUTOTRANSPLANTATION; CELL COUNT; CONTROLLED STUDY; CONVALESCENCE; DRUG USE; DRUG WITHDRAWAL; EXPERIENCE; FEMALE; FEVER; GRAFT VERSUS HOST REACTION; HEMATOPOIESIS; HOSPITALIZATION; HUMAN; HUMAN TISSUE; INCIDENCE; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; NEUTROPENIA; NEUTROPHIL; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; TIME;

ADULT; AGED; DRUG ADMINISTRATION SCHEDULE; FEMALE; FEVER; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HOSPITALIZATION; HUMANS; LEUKOCYTE COUNT; MALE; MIDDLE AGED; NEUTROPHILS; RETROSPECTIVE STUDIES; TIME FACTORS; TRANSPLANTATION, AUTOLOGOUS;

EID: 4644227910     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1704415     Document Type: Article

References (12)

1. Schmitz N, Dreger P, Zander AR et al. Results of a randomised, controlled, multicentre study of recombinant human granulocyte colony-stimulating factor (filgrastim) in patients with Hodgkin's disease and non-Hodgkin's lymphoma undergoing autologous bone marrow transplantation. Bone Marrow Transplant 1995; 15: 261-266.
2. Gorin NC, Coiffier B, Hayat M et al. Recombinant human granulocyte-macrophage colony-stimulating factor after high-dose chemotherapy and autologous bone marrow transplantation with unpurged and purged marrow in non-Hodgkin's lymphoma: a double-blind placebo-controlled trial. Blood 1992; 80: 1149-1157.
3. Torres-Gomez A, Jimenez MA, Alvarez MA et al. Optimal timing of granulocyte colony-stimulating factor (G-CSF) administration after bone marrow transplantation. A prospective randomized study. Ann Hematol 1995; 71: 65-70.
4. Faucher C, Le Corroller AG, Chabannon C et al. Administration of G-CSF can be delayed after transplantation of autologous G-CSF-primed blood stem cells: a randomized study. Bone Marrow Transplant 1996; 17: 533-536.
5. Stahel RA, Jost LM, Honegger H et al. Randomized trial showing equivalent efficacy of filgrastim 5 micrograms/kg/d and 10 micrograms/kg/d following high-dose chemotherapy and autologous bone marrow transplantation in high-risk lymphomas. J Clin Oncol 1997; 15: 1730-1735.
6. Bolwell B, Goormastic M, Dannley R et al. G-CSF post-autologous progenitor cell transplantation: a randomized study of 5, 10, and 16 micrograms/kg/day. Bone Marrow Transplant 1997; 19: 215-219.
7. Bolwell BJ, Pohlman B, Andresen S et al. Delayed G-CSF after autologous progenitor cell transplantation: a prospective randomized trial. Bone Marrow Transplant 1998; 21: 369-373.
8. 9/L neutrophils on 3 consecutive days to define myeloid recovery. Bone Marrow Transplant 2002; 30: 749-752.
9. Rihn C, Cilley F, Monreal J et al. Definition of myeloid engraftment after allogeneic hematopoietic stem cell transplantation. Blood 2002; 100: 417a-418a, (abstract #1618).
10. Ali MY, Oyama Y, Monreal J et al. Ideal or actual body weight to calculate CD34+ cell doses for autologous hematopoietic stem cell transplantation? Bone Marrow Transplant 2003; 31: 861-864.
11. Spitzer TR. Engraftment syndrome following hematopoietic stem cell transplantation. Bone Marrow Transplant 2001; 27: 893-898.
12. San Miguel JF, Hernandez MD, Gonzalez M et al. A randomized study comparing the effect of GM-CSF and G-CSF on immune reconstitution after autologous bone marrow transplantation. Br J Haematol 1996; 94: 140-147.